Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMR Vaccine Lot-to-lot Consistency in Healthy Chinese Children
NCT05161845Phase 4Completed
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Dec 2021
- Primary completion
- Apr 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of measles, mumps and rubella combined vaccine, live in measles, mumps, rubella, sponsored by Shanghai Institute of Biological Products. Started Dec 2021; status: completed.
02
Drugs
measles, mumps and rubella combined vaccine, live
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT05161845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05161845.